JP2011520996A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520996A5
JP2011520996A5 JP2011510855A JP2011510855A JP2011520996A5 JP 2011520996 A5 JP2011520996 A5 JP 2011520996A5 JP 2011510855 A JP2011510855 A JP 2011510855A JP 2011510855 A JP2011510855 A JP 2011510855A JP 2011520996 A5 JP2011520996 A5 JP 2011520996A5
Authority
JP
Japan
Prior art keywords
leukemia
acute
chronic
lymphocytic leukemia
myeloid leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011510855A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520996A (ja
JP5643192B2 (ja
Filing date
Publication date
Priority claimed from DE102008025750A external-priority patent/DE102008025750A1/de
Application filed filed Critical
Publication of JP2011520996A publication Critical patent/JP2011520996A/ja
Publication of JP2011520996A5 publication Critical patent/JP2011520996A5/ja
Application granted granted Critical
Publication of JP5643192B2 publication Critical patent/JP5643192B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011510855A 2008-05-29 2009-04-24 腫瘍を処置するためのチロシンキナーゼモジュレーターとしてのジヒドロピラゾール誘導体 Expired - Fee Related JP5643192B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008025750A DE102008025750A1 (de) 2008-05-29 2008-05-29 Dihydropyrazolderivate
DE102008025750.8 2008-05-29
PCT/EP2009/003030 WO2009143945A1 (de) 2008-05-29 2009-04-24 Dihydropyrazolderivate als tyrosinkinase modulatoren zur behandlung von tumoren

Publications (3)

Publication Number Publication Date
JP2011520996A JP2011520996A (ja) 2011-07-21
JP2011520996A5 true JP2011520996A5 (enExample) 2014-05-08
JP5643192B2 JP5643192B2 (ja) 2014-12-17

Family

ID=40822993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011510855A Expired - Fee Related JP5643192B2 (ja) 2008-05-29 2009-04-24 腫瘍を処置するためのチロシンキナーゼモジュレーターとしてのジヒドロピラゾール誘導体

Country Status (16)

Country Link
US (1) US8404685B2 (enExample)
EP (1) EP2300434B1 (enExample)
JP (1) JP5643192B2 (enExample)
KR (1) KR20110010821A (enExample)
CN (1) CN102046605B (enExample)
AR (1) AR071951A1 (enExample)
AU (1) AU2009253432B2 (enExample)
BR (1) BRPI0912970A2 (enExample)
CA (1) CA2726009C (enExample)
DE (1) DE102008025750A1 (enExample)
EA (1) EA018394B1 (enExample)
ES (1) ES2507573T3 (enExample)
IL (1) IL209418A (enExample)
MX (1) MX2010012804A (enExample)
WO (1) WO2009143945A1 (enExample)
ZA (1) ZA201009085B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012279416B2 (en) 2011-07-01 2017-04-06 Merck Patent Gmbh Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
CN104662014B (zh) * 2012-07-10 2017-02-22 阿雷斯贸易股份有限公司 嘧啶吡唑基衍生物
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
JP4471404B2 (ja) 1996-02-13 2010-06-02 アストラゼネカ ユーケイ リミテッド Vegfインヒビターとしてのキナゾリン誘導体
ATE211134T1 (de) 1996-03-05 2002-01-15 4-anilinochinazolin derivate
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
CA2410562A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
WO2003079973A2 (en) 2002-03-08 2003-10-02 Merck & Co., Inc. Mitotic kinesin inhibitors
DE102005038537A1 (de) 2005-08-16 2007-02-22 Merck Patent Gmbh 1-Acyldihydropyrazolderivate

Similar Documents

Publication Publication Date Title
JP2012513418A5 (enExample)
WO2010017515A3 (en) Breast cancer specific markers and methods of use
JP2012501986A5 (enExample)
EP4335929C0 (en) NON-INVASIVE DETERMINATION OF METHYLOMA IN A TUMOR FROM PLASMA
JP2009039101A5 (enExample)
MY160445A (en) Dual Variable Domain Immunoglobulins And Uses Thereof
JP2015504870A5 (enExample)
EP4559481A3 (en) Methods of treatment of cholestatic diseases
PH12013500337A1 (en) Dual variable domain immunoglobulins and uses thereof
PH12013500867A1 (en) Dual variable domain immunoglobulins and uses thereof
EA201200507A1 (ru) Применение активаторов никотинового ацетилхолинового рецептора альфа 7
EP3702782A3 (en) Methods and compositions for amplified electrochemiluminescence detection
WO2009127414A3 (en) Inhibition of angiogenesis and tumor metastasis
EP4279925A3 (en) Dulaglutide for the treatment of chronic kidney disease
JP2011520996A5 (enExample)
JP2010536896A5 (enExample)
JP2009532412A5 (enExample)
CL2014001823A1 (es) Procedimiento de preparacion estereoselectiva de un compuesto derivado de 9-hidroxi-5-oxo-1,4-diaza-espiro [5.5] undecano; compuestos intermediarios; uso en el tratamiento de enfermedades tumorales, enfermedades del pulmon y de las vias respiratorias.
BRPI0822415A2 (pt) Conjugado de hidróxipolímero modificado, uso de conjugado de hidroxipolímero modificado, composição para matar tumor, e, métodos para produzir o conjugado de hidroxipolímero modificado e para tratar câncer.
PH12016501127A1 (en) Adenosine a1 agonists as medicaments against renal diseases
ICHIE The Beginning of Music & Acoustical Medicine
WO2013059152A3 (en) Methods and kits for selection of a treatment for breast cancer
RU2007140029A (ru) Способ лечения хронической сердечной недостаточности
JP2008119585A5 (enExample)
TH175491A (th) การใช้โมเลกุลยึดจับ เซมาโฟริน-4D สำหรับการบำบัดโรค หลอดเลือดแข็ง(atherosclerosis)